» Articles » PMID: 38948148

Filamentation and Inhibition of Prokaryotic CTP Synthase with Ligands

Overview
Journal mLife
Date 2024 Jul 1
PMID 38948148
Authors
Affiliations
Soon will be listed here.
Abstract

Cytidine triphosphate synthase (CTPS) plays a pivotal role in the de novo synthesis of cytidine triphosphate (CTP), a fundamental building block for RNA and DNA that is essential for life. CTPS is capable of directly binding to all four nucleotide triphosphates: adenine triphosphate, uridine triphosphate, CTP, and guanidine triphosphate. Furthermore, CTPS can form cytoophidia in vivo and metabolic filaments in vitro, undergoing regulation at multiple levels. CTPS is considered a potential therapeutic target for combating invasions or infections by viral or prokaryotic pathogens. Utilizing cryo-electron microscopy, we determined the structure of CTPS (ecCTPS) filament in complex with CTP, nicotinamide adenine dinucleotide (NADH), and the covalent inhibitor 6-diazo-5-oxo- l-norleucine (DON), achieving a resolution of 2.9 Å. We constructed a phylogenetic tree based on differences in filament-forming interfaces and designed a variant to validate our hypothesis, providing an evolutionary perspective on CTPS filament formation. Our computational analysis revealed a solvent-accessible ammonia tunnel upon DON binding. Through comparative structural analysis, we discern a distinct mode of CTP binding of ecCTPS that differs from eukaryotic counterparts. Combining biochemical assays and structural analysis, we determined and validated the synergistic inhibitory effects of CTP with NADH or adenine on CTPS. Our results expand our comprehension of the diverse regulatory aspects of CTPS and lay a foundation for the design of specific inhibitors targeting prokaryotic CTPS.

Citing Articles

Cytoophidium complexes resonate with cell fates.

Li Y, Liu J Cell Mol Life Sci. 2025; 82(1):54.

PMID: 39836171 PMC: 11751279. DOI: 10.1007/s00018-025-05578-z.


The Impact of Developmental and Metabolic Cues on Cytoophidium Formation.

Zhang Y, Liu J Int J Mol Sci. 2024; 25(18).

PMID: 39337544 PMC: 11432437. DOI: 10.3390/ijms251810058.

References
1.
Hofer A, Steverding D, Chabes A, Brun R, Thelander L . Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness. Proc Natl Acad Sci U S A. 2001; 98(11):6412-6. PMC: 33482. DOI: 10.1073/pnas.111139498. View

2.
Mori G, Chiarelli L, Esposito M, Makarov V, Bellinzoni M, Hartkoorn R . Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. Chem Biol. 2015; 22(7):917-27. PMC: 4521081. DOI: 10.1016/j.chembiol.2015.05.016. View

3.
Levitzki A, Koshland Jr D . Cytidine triphosphate synthetase. Covalent intermediates and mechanisms of action. Biochemistry. 1971; 10(18):3365-71. DOI: 10.1021/bi00794a008. View

4.
Zhou X, Guo C, Hu H, Zhong J, Sun Q, Liu D . Drosophila CTP synthase can form distinct substrate- and product-bound filaments. J Genet Genomics. 2020; 46(11):537-545. DOI: 10.1016/j.jgg.2019.11.006. View

5.
Chang Y, Carman G . CTP synthetase and its role in phospholipid synthesis in the yeast Saccharomyces cerevisiae. Prog Lipid Res. 2008; 47(5):333-9. PMC: 2583782. DOI: 10.1016/j.plipres.2008.03.004. View